Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Voltage-gated potassium channel Kv3.4 is a crucial component in mediating high-frequency neuronal firing in the brain and other neural tissues. It is involved in shaping action potential duration and modulating neurotransmitter release, particularly in axons and nerve terminals. Kv3.4 channels are significant in nociceptive signaling and are known to be sensitive to both chemical and enzymatic modulators, such as protein kinase C (PKC), which can alter their inactivation properties.
High voltage-activation, rapid kinetics contributing to fast A-type potassium currents, modulation by PKC phosphorylation affecting inactivation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated potassium channel KCNC4 (Kv3.4).